Noticias de CRDF_US
Noticias del mercado
Últimas noticias sobre CRDF_US — 184 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.
Los datos actualizados de la Fase 2 CRDF-004 se presentarán durante la sesión oral rápida de ASCO 2026 el 2 de junio de 2026; Webcast para inversores programado para el 3 de junio de 2026 a las 8:30 am...
Cardiff Oncology sues Nerviano as analyst backs Onvansertib defense
Los datos actualizados de la Fase 2 CRDF-004 se presentarán durante la sesión oral rápida de ASCO 2026 el 2 de junio de 2026; Webcast para inversores programado para el 3 de junio de 2026 a las 8:30 am...
Cardiff Oncology sues Nerviano as analyst backs Onvansertib defense
Cardiff Oncology sues Nerviano as analyst backs Onvansertib defense
Cardiff Oncology And 2 Other Promising Penny Stocks For Your Watchlist
Cardiff Oncology, Inc. (CRDF) has filed documents with the U.S. Securities and Exchange Commission (SEC), disclosing that it has initiated a lawsuit against Nerviano Medical Sciences, accusing the latter of…
Cardiff Oncology, Inc. (CRDF) has filed documents with the U.S. Securities and Exchange Commission (SEC), disclosing that it has initiated a lawsuit against Nerviano Medical Sciences, accusing the latter of…
Cardiff Oncology, Inc. (CRDF) has filed documents with the U.S. Securities and Exchange Commission (SEC), disclosing that it has initiated a lawsuit against Nerviano Medical Sciences, accusing the latter of…
Is Cardiff Oncology (CRDF) 5.1% Undervalued After Q1 2026 Earnin
Cardiff Oncology (CRDF) Secures Funding Through 1Q27
Cardiff Oncology (CRDF) Reports Positive Trial Data and Leadersh
Página 3 de 10
